Acute myeloid leukemia trials in Spain

In Spain 62 Also abroad 761

62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Where
Alicante, Cáceres, Madrid, Sevilla, Valencia
Age
18 years and over
People
78 worldwide
Run by
AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00
Phase 1/2Not yet taking people in Spain
An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid Leukaemia
Where
Barcelona
Age
18 years and over
People
143 worldwide
Run by
Advesya SAS
See details and how to joinNCT06281847
Phase 1/2Taking people
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Where
Alicante, Barcelona, Madrid, Oviedo, Pozuelo de Alarcón, Salamanca, Valencia
Age
18 years and over
People
240 worldwide
Run by
Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00
Phase 3Taking people
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Where
Barcelona, Girona, Valencia
Age
18 years and over
People
227 worldwide
Run by
Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07075016
Phase 2Taking people
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Where
Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Oviedo, Palma, Santander, Santiago de Compostela, Sevilla, Valencia, Zaragoza
Age
1 month to 18 years
People
60 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01
Phase 3Not yet taking people in Spain
A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction
Where
Albacete, Alicante, Badalona, Cáceres, Córdoba, Madrid, Sevilla, Terrassa, Valencia
Age
70 years and over
People
262 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07082452 · EU 2025-521634-29-00
Phase 3Taking people
Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Where
Madrid
Age
Up to 18 years
People
170 worldwide
Run by
Vastra Gotaland Region
See details and how to joinNCT05477589
Phase 3Taking people
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years
Where
Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Palma, Santiago de Compostela, Sevilla, Valencia, Zaragoza
Age
Up to 64 years
People
730 worldwide
Run by
Vaestra Goetalandsregionen
See details and how to joinNCT01828489 · EU 2024-518254-16-00
Phase 1/2Not yet taking people in Spain
An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerability, and clinical activity in patients with relapsed/refractory acute myeloid leukaemia (RESOLVE AML 001)
Where
Barcelona
Age
18 years and over
People
61 worldwide
Run by
CanCell Therapeutics
See details and how to join2023-506865-71-00 · EU 2023-506865-71-00
Phase 2Not yet taking people in Spain
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Where
Seville
Age
18 years to 50 years
People
58
Run by
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT06598969
Phase 2Not yet taking people in Spain
TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
Where
Sevilla
Age
50 years to 99 years
People
34
Run by
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT06602323 · EU 2024-514483-11-00
Phase 2Taking people
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Where
Valencia
Age
Up to 18 years
People
89 worldwide
Run by
Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00